Tevogen Bio Holdings Inc.TVGNNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-12.00M
↓ 38% below average
Average (3y)
$-8.71M
Historical baseline
Range
High:$-5.38M
Low:$-12.00M
CAGR
+30.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-12.00M | -44.5% |
| 2023 | $-8.30M | +9.1% |
| 2022 | $-9.13M | -69.6% |
| 2021 | $-5.38M | - |